DMKJ
WHWK

David M. Knott Jr’s Whitehawk Therapeutics WHWK Stock Holding History

David M. Knott Jr’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-265,000
Closed -$1.28M – 135
2023
Q3 		$1.28M Buy
265,000
+4,000
+2% +$23.3K 0.49% 35
2023
Q2 		$1.78M Buy
261,000
+77,312
+42% +$601K 0.71% 27
2023
Q1 		$1.33M Buy
183,688
+156,446
+574% +$1.67M 0.52% 36
2022
Q4 		$350K Sell
27,242
-21,797
-44% -$285K 0.13% 68
2022
Q3 		$693K Buy
49,039
+35,000
+249% +$460K 0.29% 58
2022
Q2 		$173K Buy
+14,039
New +$209K 0.07% 91

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

David M. Knott Jr's WHWK Position: Q4 2023 in Review

David M. Knott Jr sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 265,000 shares — an estimated $1.28M sold.

David M. Knott Jr first reported a position in WHWK in Q2 2022 and held it in 6 quarters. The position peaked at $1.78M in Q2 2023. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • David M. Knott Jr reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
  • David M. Knott Jr sold 265,000 Whitehawk Therapeutics shares in Q4 2023, an estimated $1.28M.
  • David M. Knott Jr first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 6 quarters.
  • David M. Knott Jr's Whitehawk Therapeutics position peaked at $1.78M in Q2 2023.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.